Lupin partners ERN to launch asthma and COPD treatment in Spain
Lupin Ltd has entered into a strategic collaboration with Spanish pharmaceutical company LABORATORIOS ERN S.A. for the launch of Luforbec (beclometasone/formoterol) in Spain, marking another step in the Indian drugmaker’s efforts to expand its respiratory portfolio across key international markets. The therapy, delivered through a pressurised metered dose inhaler (pMDI), is indicated for the treatment…
